Skip to main content
Patrick Hu, MD, Oncology, Nashville, TN

Patrick J Hu MD PhD

Gastrointestinal Cancer, Hematologic Oncology


Associate Professor of Medicine, Cell and Developmental Biology, and Cancer Biology, Vanderbilt University School of Medicine

Join to View Full Profile
  • 3601 Pierce AveNashville, TN 37232

  • Phone+1 615-936-2000

Dr. Hu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalPost-Doctoral Fellowship, 1999 - 2005
  • Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1998 - 2001
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1995 - 1998
  • New York University School of Medicine
    New York University School of MedicineClass of 1995
  • Harvard University
    Harvard UniversityA.B., Biology, cum laude, 1981 - 1985

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2016 - 2027
  • MI State Medical License
    MI State Medical License 2005 - 2018
  • MA State Medical License
    MA State Medical License 1998 - 2007
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Elected Member The American Society for Clinical Investigation, 2011

Publications & Presentations

PubMed

Journal Articles

  • Insulin/insulin-like growth factor signaling in C. elegans  
    Murphy CT, Hu PJ, Wormbook

Press Mentions

  • A Common Insulin Signaling Pathway Across Cancer and Diabetes
    A Common Insulin Signaling Pathway Across Cancer and DiabetesDecember 4th, 2019

Grant Support

  • FoxO Phosphorylation in the Control of C. elegans Life SpanNational Institute on Aging2012–Present
  • EAK-7, a Novel Regulator of FoxO Tumor SuppressorsAmerican Cancer Society2010–Present
  • Genetic Modifiers of In Vivo Hypoxia ResistanceAmerican Heart Association2011–2012
  • Novel Regulators Of FOXO Transcription FactorsNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2009
  • Genetic Analysis Of DAF-18/PTEN Signaling In C.ElegansNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
  • Genetic Analysis Of DAF-18/PTEN Signaling In C.ElegansNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2004

Professional Memberships

  • American Society of Clinical Investigation
    Member
  • Genetics Society of America
    Member

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: